Arya Sciences News Today

Adagio Medical, Inc., a privately held innovator in catheter ablation technologies for treatment of cardiac arrhythmias, announced Wednesday a definitive agreement with ARYA Sciences Acquisition Corp IV (ARYD), a special purpose acquisition company sponsored by an affiliate of Perceptive Advisors, LLC, for a business combination.

Cerevel is a CNS specialist drug developer formed as a result of a spinout of former Pfizer neuroscience assets. The current valuation isn't attractive.